Understanding how mitochondrial membrane stabilization, metabolic signaling, and exercise-associated gene pathways differ across three experimental compounds.
Mitochondria are best known as the structures responsible for producing cellular energy. But modern research has revealed that their function extends far beyond the production of adenosine triphosphate (ATP).
Mitochondria also participate in cellular communication, metabolic adaptation, oxidative stress responses, and processes associated with biological aging.
These discoveries have introduced new research questions about whether mitochondrial function can be influenced through specific molecular pathways.
Three compounds frequently discussed in this field are SS-31 (elamipretide), MOTS-C, and SLU-PP-332.
Although all three have been investigated in relation to mitochondrial function, they do not operate through the same mechanisms.
SS-31 primarily interacts with mitochondrial membrane structures. MOTS-C participates in metabolic signaling pathways. SLU-PP-332 activates nuclear receptors involved in exercise-associated gene expression.
Understanding these differences provides a clearer picture of the expanding field of mitochondrial research.
Why Mitochondrial Function Matters
Mitochondria are specialized cellular structures that produce much of the ATP required for biological activity.
ATP supports processes including muscle contraction, protein synthesis, cellular transport, and tissue maintenance.
A major portion of ATP production occurs through oxidative phosphorylation, a process involving protein complexes embedded within the inner mitochondrial membrane.
These complexes collectively form the electron transport chain.
During this process, electrons move through a series of molecular structures, helping generate an electrochemical gradient used to produce ATP.
However, mitochondrial performance is influenced by much more than the electron transport chain alone.
Important factors include:
The structural integrity of mitochondrial membranes
The activity of enzymes involved in energy production
Cellular responses to oxidative stress
The production and maintenance of mitochondria
Communication between mitochondria and the cell nucleus
SS-31, MOTS-C, and SLU-PP-332 each relate to different parts of this broader biological system.
1. SS-31: Research Into Mitochondrial Membrane Stability
SS-31, also known as elamipretide, is a synthetic tetrapeptide studied for its interaction with the inner mitochondrial membrane.
One of the defining features of this membrane is the presence of a specialized phospholipid called cardiolipin.
What is cardiolipin?
Cardiolipin is an important structural component of the inner mitochondrial membrane.
It helps organize proteins involved in oxidative phosphorylation and contributes to the stability of mitochondrial membrane structures.
Changes in cardiolipin composition, distribution, or oxidation can interfere with mitochondrial performance.
Because of this relationship, cardiolipin has attracted considerable attention in research involving mitochondrial dysfunction.
How does SS-31 interact with cardiolipin?
SS-31 associates with cardiolipin-containing mitochondrial membranes.
Research suggests this interaction can influence membrane organization, respiratory protein function, and cellular responses to oxidative stress.
The proposed mechanisms include:
Supporting inner mitochondrial membrane organization
Influencing electron transport chain efficiency
Modifying mitochondrial oxidative stress responses
Affecting ATP-production processes under certain conditions
The central research concept is that stabilizing the environment in which mitochondrial respiratory proteins operate may help preserve cellular energy production.
What have researchers observed?
Preclinical studies have investigated SS-31 in experimental models involving cardiac, skeletal muscle, renal, and mitochondrial dysfunction.
Some studies reported improvements in mitochondrial function or tissue-level outcomes.
However, results in human clinical trials have been mixed.
A large randomized phase 3 trial in primary mitochondrial myopathy did not demonstrate significant improvement in its primary walking-distance and fatigue endpoints.
More recently, elamipretide received accelerated approval in the United States for improving muscle strength in qualifying patients with Barth syndrome, a rare mitochondrial disorder.
This disease-specific approval reflects a substantially different evidence base from claims concerning general energy enhancement or exercise performance.
Why SS-31 is scientifically interesting
SS-31 represents a research strategy centered on mitochondrial structure.
Rather than primarily activating metabolic signaling pathways, it interacts with the membrane environment where oxidative phosphorylation occurs.
This makes SS-31 an important subject in research examining the relationship between mitochondrial architecture and energy production.
2. MOTS-C: A Mitochondrial Peptide Involved in Metabolic Signaling
MOTS-C is a naturally occurring, mitochondrial-derived peptide composed of 16 amino acids.
Its name comes from mitochondrial open reading frame of the 12S rRNA type-c.
Unlike SS-31, which is studied for membrane interactions, MOTS-C has attracted attention for its involvement in cellular metabolism and adaptive stress responses.
The connection between MOTS-C and AMPK
One of the most important pathways associated with MOTS-C is AMP-activated protein kinase, commonly abbreviated AMPK.
AMPK functions as a cellular energy sensor.
When cellular energy availability changes, AMPK helps coordinate metabolic responses that influence how cells produce and utilize energy.
These responses can include changes in glucose metabolism, fatty acid oxidation, and other energy-related processes.
Original research published in Cell Metabolism identified a relationship between MOTS-C, the folate-purine metabolic pathway, and AMPK activation.
This discovery suggested that mitochondrial DNA can contribute to metabolic regulation through signaling peptides.
What happens during exercise?
Exercise creates increased energy demand in skeletal muscle.
Cells respond through interconnected pathways that regulate energy availability, mitochondrial function, and metabolic adaptation.
Research has shown that endogenous MOTS-C expression can increase in response to exercise.
A 2021 study published in Nature Communications reported exercise-associated changes in MOTS-C levels in humans.
The same research investigated MOTS-C administration in mice and reported improvements in physical capacity across several age groups.
These findings support the idea that MOTS-C participates in the body's response to metabolic stress.
MOTS-C, PGC-1α, and mitochondrial adaptation
PGC-1α is an important regulator of mitochondrial biogenesis, the process through which cells increase or maintain their mitochondrial machinery.
AMPK signaling can interact with PGC-1α-associated pathways as part of cellular adaptation to exercise.
Researchers have investigated how MOTS-C-related metabolic signaling fits within this broader network.
This has generated interest in several research areas:
Metabolic flexibility
Insulin sensitivity
Skeletal muscle adaptation
Mitochondrial function
Age-related physical decline
Although these pathways overlap with exercise physiology, experimental MOTS-C administration is not equivalent to performing exercise.
What did animal studies show?
A foundational 2015 study reported that MOTS-C influenced metabolic homeostasis in mice.
Experimental findings included protection against certain diet-associated metabolic disturbances and changes in insulin sensitivity.
The 2021 study further reported improvements in physical performance in young, middle-aged, and older mice.
These results have made MOTS-C an important subject in research involving mitochondrial signaling and metabolic aging.
However, controlled human evidence demonstrating similar benefits from administered MOTS-C remains limited.
3. SLU-PP-332: Activating Exercise-Associated Gene Pathways
SLU-PP-332 represents a different experimental approach.
Unlike SS-31 and MOTS-C, SLU-PP-332 is not a peptide.
It is a synthetic small molecule developed to activate a group of nuclear receptors known as estrogen-related receptors, or ERRs.
These receptors participate in regulating genes associated with cellular metabolism and energy expenditure.
What are estrogen-related receptors?
Estrogen-related receptors are nuclear receptors that influence the expression of genes associated with mitochondrial function and oxidative metabolism.
There are three principal subtypes:
ERRα
ERRβ
ERRγ
Despite their names, estrogen-related receptors are not the same as classical estrogen receptors.
They are involved in broader processes associated with metabolic regulation.
How does SLU-PP-332 work?
Research has identified SLU-PP-332 as an agonist of all three major ERR subtypes, with particularly strong activity toward ERRα.
An agonist is a compound that activates a receptor and its associated biological signaling.
By activating ERR pathways, SLU-PP-332 can influence genes involved in mitochondrial and skeletal muscle metabolism.
Researchers have examined changes in:
Mitochondrial respiratory activity
Oxidative muscle fiber characteristics
Fatty acid metabolism
Exercise-associated gene expression
Physical endurance in animal models
This direct interaction with ERR receptors distinguishes SLU-PP-332 from the more upstream metabolic signaling associated with MOTS-C.
Why is it called an exercise mimetic?
An exercise mimetic is an experimental compound designed to reproduce certain molecular or physiological adaptations associated with exercise.
In a 2023 study published in ACS Chemical Biology, researchers examined SLU-PP-332 in skeletal muscle cells and mice.
The study reported increased mitochondrial function in experimental cell systems and enhanced endurance in treated mice.
In one experimental comparison, treated mice ran approximately 70% longer and 45% farther than control mice.
The researchers also observed changes in oxidative skeletal muscle fiber characteristics.
These findings suggest that targeted ERR activation can reproduce some exercise-associated metabolic responses in animals.
However, the term exercise mimetic should not be interpreted as evidence that a compound can replace the full biological effects of physical activity in humans.
Additional metabolic research
A 2024 study examined SLU-PP-332 in mouse models of obesity and metabolic dysfunction.
Researchers reported changes in energy expenditure, fatty acid oxidation, fat mass accumulation, and insulin sensitivity.
These findings expanded interest in ERR activation as a possible research strategy for metabolic disorders.
Importantly, these are preclinical findings.
Human effectiveness, appropriate exposure levels, and long-term safety have not been established.
SS-31 vs. MOTS-C vs. SLU-PP-332: How Do They Compare?
Although the three compounds are discussed in the same mitochondrial research field, they target different biological processes.
Research characteristicSS-31MOTS-CSLU-PP-332Compound typeSynthetic tetrapeptideMitochondrial-derived peptideSynthetic small moleculePrimary research targetMitochondrial membrane and cardiolipinMetabolic stress signalingEstrogen-related receptorsKey mechanismMembrane-associated mitochondrial effectsAMPK-associated metabolic regulationERR-mediated gene activationMain research areasMitochondrial dysfunction and membrane structureMetabolic homeostasis and physical adaptationOxidative metabolism and exercise-associated gene expressionHuman evidenceClinical trials and limited disease-specific approvalEndogenous MOTS-C exercise observations; limited administration dataPredominantly preclinicalMajor limitationResults vary by disease and study endpointLimited controlled human administration studiesNo established human clinical efficacy
Three different biological strategies
A useful way to understand these compounds is to separate them into three research approaches.
SS-31: The mitochondrial membrane approach
Investigates whether interaction with cardiolipin and membrane-associated proteins can influence mitochondrial function.
MOTS-C: The metabolic signaling approach
Examines how a naturally occurring mitochondrial peptide communicates metabolic conditions and participates in cellular adaptation.
SLU-PP-332: The nuclear receptor approach
Investigates whether direct ERR activation can stimulate gene-expression programs resembling selected metabolic adaptations to exercise.
These distinctions explain why compounds associated with the same broad subject—mitochondrial function—can produce very different experimental effects.
What Do These Compounds Tell Us About Biological Aging?
Mitochondrial biology is closely connected to aging research.
As organisms age, changes may occur in mitochondrial function, metabolic flexibility, cellular stress responses, and the maintenance of skeletal muscle.
Researchers are interested in whether influencing specific mitochondrial pathways might affect age-associated biological changes.
SS-31 has been studied in conditions involving mitochondrial dysfunction.
MOTS-C has been investigated for its relationship with age-dependent physical performance and metabolic homeostasis.
SLU-PP-332 has been explored for its ability to activate exercise-associated metabolic gene pathways.
Each represents a different way of studying the connection between mitochondrial activity and cellular adaptation.
However, improvements in mitochondrial biomarkers, exercise performance in mice, or disease-specific outcomes do not establish that a compound extends human lifespan.
Longevity remains a broader research question requiring long-term human evidence.
Important Research Limitations
While these compounds have generated substantial scientific interest, several distinctions remain important.
Laboratory findings versus clinical outcomes
Changes in cellular respiration, protein expression, or mitochondrial activity are useful experimental measurements.
They are not interchangeable with demonstrated improvements in human health or physical performance.
Animal studies versus human studies
Mouse models provide valuable insights into biological mechanisms, but differences between species can affect how findings translate to humans.
Different mechanisms, different safety questions
SS-31 has undergone human clinical investigation, providing more direct information about its effects in certain disease populations.
MOTS-C has a growing body of experimental research, but limited controlled human evidence concerning administered synthetic MOTS-C.
SLU-PP-332 has been studied primarily in laboratory and animal systems. Its long-term effects on receptor signaling and cellular regulation require further investigation.
Potential interactions between growth-related signaling, abnormal cell proliferation, and metabolic pathways also warrant continued scientific study rather than assumptions about either safety or harm.
The Future of Mitochondrial Research
The growing interest in mitochondrial compounds reflects a larger shift in how researchers understand cellular energy systems.
Mitochondria are not simply passive ATP-producing structures.
They also help coordinate metabolic responses, cellular signaling, and adaptation to changing physiological conditions.
SS-31, MOTS-C, and SLU-PP-332 demonstrate three distinct approaches to investigating these functions.
SS-31 centers on mitochondrial membrane biology.
MOTS-C provides insight into mitochondrial-derived signaling peptides and metabolic regulation.
SLU-PP-332 allows researchers to study the effects of direct activation of exercise-associated nuclear receptors.
Together, these compounds illustrate the diversity of strategies being investigated in mitochondrial biology.
The most promising research direction is not necessarily identifying a single compound that increases energy production. It is understanding how mitochondrial structure, signaling, and gene regulation interact to maintain cellular function.
The future of mitochondrial research may depend as much on understanding communication between cellular systems as it does on understanding ATP production itself.
Published Scientific References
1. The Mitochondrial-Derived Peptide MOTS-C Promotes Metabolic Homeostasis and Reduces Obesity and Insulin Resistance
Lee C, et al. Cell Metabolism. 2015.
Foundational research identifying MOTS-C and its relationship with the folate-purine-AMPK metabolic pathway.
2. MOTS-C Is an Exercise-Induced Mitochondrial-Encoded Regulator of Age-Dependent Physical Decline and Muscle Homeostasis
Reynolds JC, et al. Nature Communications. 2021.
Reports exercise-associated endogenous MOTS-C changes in humans and experimental physical-performance findings in mice.
3. Synthetic ERRα/β/γ Agonist Induces an ERRα-Dependent Acute Aerobic Exercise Response and Enhances Exercise Capacity
Billon C, et al. ACS Chemical Biology. 2023.
Describes SLU-PP-332 activity at estrogen-related receptors and experimental changes in mitochondrial function and mouse endurance.
4. A Synthetic ERR Agonist Alleviates Metabolic Syndrome
Billon C, et al. Journal of Pharmacology and Experimental Therapeutics. 2024.
Examines SLU-PP-332 in mouse models involving obesity, metabolic regulation, and insulin sensitivity.
5. Efficacy and Safety of Elamipretide in Individuals With Primary Mitochondrial Myopathy: The MMPOWER-3 Randomized Clinical Trial
Neurology. 2023.
Reports results of a randomized phase 3 clinical trial investigating elamipretide in primary mitochondrial myopathy.
6. FDA: Accelerated Approval of Elamipretide for Barth Syndrome
September 2025.
Documents the disease-specific regulatory milestone for elamipretide and the clinical evidence supporting the decision.
DeSoto Peptides Research Journal — This article discusses published research involving mitochondrial biology and experimental compounds. Research information is provided for scientific and educational purposes. It does not establish clinical effectiveness for unapproved applications or provide medical advice.